Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Research article

Association between skirt size and chronic liver disease in post-menopausal women: a prospective cohort study within the United Kingdom Trial of Ovarian Cancer Screening (UKCTOCS)

Authors: P. M. Trembling, S. Apostolidou, A. Gentry-Maharaj, J. Parkes, A. Ryan, S. Tanwar, M. Burnell, U. Menon, W. M. Rosenberg

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

We investigated the association between self-reported skirt size (SS) and change in SS, and incidence of chronic liver disease (CLD) in a prospective cohort study of women recruited to the UKCTOCS trial.

Methods

Women recruited to UKCTOCS in England without documented CLD self-reported their current UK SS during trial participation and were asked to recall their SS when aged in 20s (via completion of a questionnaire 3–5 years after recruitment). Participants were followed up via electronic health record linkage and hazard ratios (HR) calculated for incident liver-related events (LRE).

Results

Three hundred twenty-two (0.3%) of 94,124 women experienced a first LRE. Compared to SS ≤ 16, rates of LRE were higher in the SS ≥ 18 groups (both when aged in 20s and at questionnaire completion). Event rates were higher if there was no change in SS or an increase in SS, compared to a decrease in SS.
In the models adjusted for potential confounders, HRs for LRE were higher in the groups of women reporting SS ≥ 18 both when aged in 20s (HR = 1.39 (95% CI; 0.87–2.23)) and at questionnaire completion (HR = 1.37 (95% CI; 1.07–1.75)). Compared to a decrease in SS, HRs were higher in the no change (HR = 1.78 (95% CI; 0.95–3.34)) and increase (HR = 1.80 (95% CI; 1.01–3.21)) groups.

Conclusion

CLD is associated with high SS and an increase in SS over time. These data suggest SS can be used in simple public health messages about communicating the risk of liver disease.

Trial Registration

UKCTOCS is registered as an International Standard Randomised Controlled Trial, number ISRCTN22488978. Registered 06/04/2000.
Appendix
Available only for authorised users
Literature
1.
Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Lancet. 2006;367:52–6.CrossRefPubMed
2.
Williams R, Aspinall R, Bellis M, Camps-Walsh G, Cramp M, Dhawan A, et al. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet. 2014;384:1953–97.CrossRefPubMed
3.
Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, et al. The epidemiology of cirrhosis in the United States: a population-based study. J Clin Gastroenterol. 2015;49:690–6.CrossRefPubMed
4.
Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844–50.CrossRefPubMed
5.
Chang H, Simonsick EM, Ferrucci L, Cooper JA. Validation study of the body adiposity index as a predictor of percent body fat in older individuals: findings from the BLSA. J Gerontol A Biol Sci Med Sci. 2014;69:1069–75.CrossRefPubMed
6.
7.
Trembling PM, Apostolidou S, Gentry-Maharaj A, Parkes J, Ryan A, Tanwar S, et al. Risk of chronic liver disease in post-menopausal women due to body mass index, alcohol and their interaction: a prospective nested cohort study within the United Kingdom collaborative trial of ovarian Cancer screening (UKCTOCS). BMC Public Health. 2017;17(1):603.CrossRefPubMedPubMedCentral
8.
Fourkala EO, Burnell M, Cox C, Ryan A, Salter LC, Gentry-Maharaj A, et al. Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK collaborative trial of ovarian Cancer screening (UKCTOCS). BMJ Open. 2014;24(9):e005400.CrossRef
9.
Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK collaborative trial of ovarian Cancer screening (UKCTOCS). Lancet Oncol. 2009;10:327–40.CrossRefPubMed
10.
Menon U, Gentry-Maharaj A, Ryan A, Sharma A, Burnell M, Hallett R, et al. Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study. BMJ. 2008;337:a2079.CrossRefPubMedPubMedCentral
11.
Gentry-Maharaj A, Glazer C, Burnell M, Ryan A, Berry H, Kalsi J, et al. Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK collaborative trial of ovarian Cancer screening (UKCTOCS). BMJ Open. 2017;7:e011822.CrossRefPubMedPubMedCentral
12.
Menon U, Ryan A, Kalsi J, Gentry-Maharaj A, Dawnay A, Habib M, et al. Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom collaborative trial of ovarian Cancer screening. J Clin Oncol. 2015;33:2062–71.CrossRefPubMedPubMedCentral
13.
Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK. Ovarian cancer screening and mortality in the UK collaborative trial of ovarian Cancer screening (UKCTOCS): a randomised controlled trial. Lancet. 2016;387(10022):945–56.CrossRefPubMedPubMedCentral
14.
Han TS, Gates E, Truscott E, Lean ME. Clothing size as an indicator of adiposity, ischaemic heart disease and cardiovascular risks. J Hum Nutr Diet. 2005;18:423–30.CrossRefPubMed
15.
British Standards Institution. BS 3666:1982 Specification for size designation of women’s wear. London.
16.
17.
Burnell M, Gentry-Maharaj A, Ryan A, Apostolidou S, Habib M, Kalsi J, et al. Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials. Trials. 2011;12:61.CrossRefPubMedPubMedCentral
18.
19.
Donato GB, Fuchs SC, Oppermann K, Bastos C, Spritzer PM. Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause. 2006;13:280–5.CrossRefPubMed
20.
Garcia-Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology. 2010;51:1445–9.CrossRefPubMedPubMedCentral
21.
22.
Health and Social Care Information Centre. Health Survey for England 2015: Adult alcohol consumption. HSIC, 2016.
23.
Department of Health. Adult alcohol statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April 2013 to 31 march 2014. London: Department of Health; 2014.
24.
Bolton-Smith C, Woodward M, Tunstall-Pedoe H, Morrison C. Accuracy of the estimated prevalence of obesity from self reported height and weight in an adult Scottish population. J Epidemiol Community Health. 2000;54:143–8.CrossRefPubMedPubMedCentral
25.
Hill A, Roberts J. Body mass index: a comparison between self-reported and measured height and weight. J Public Health Med. 1998;20(2):206–10.CrossRefPubMed
26.
Nieto-Garcia FJ, Bush TL, Keyl PM. Body mass definitions of obesity: sensitivity and specificity using self-reported weight and height. Epidemiology. 1990;1:146–52.CrossRefPubMed
27.
Roberts RJ. Can self-reported data accurately describe the prevalence of overweight? Public Health. 1995;109(4):275–84.CrossRefPubMed
28.
Kuskowska-Wolk A, Karlsson P, Stolt M, Rössner S. The predictive validity of body mass index based on self-reported weight and height. Int J Obes. 1989;13:441–53.PubMed
29.
Dahl AK, Hassing LB, Fransson EI, Pedersen NL. Agreement between self-reported and measured height, weight and body mass index in old age--a longitudinal study with 20 years of follow-up. Age Ageing. 2010;39:445–51.CrossRefPubMedPubMedCentral
30.
Stevens J, Keil JE, Waid LR, Gazes PC. Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population. Am J Epidemiol. 1990;132:1156–63.CrossRefPubMed
31.
Dahl AK, Reynolds CA. Accuracy of recalled body weight--a study with 20-years of follow-up. Obesity (Silver Spring). 2013;21:1293–8.CrossRef
32.
Perry GS, Byers TE, Mokdad AH, Serdula MK, Williamson DF. The validity of self-reports of past body weights by U.S. adults. Epidemiology. 1995;6:61–6.CrossRefPubMed
33.
Must A, Willett WC, Dietz WH. Remote recall of childhood height, weight, and body build by elderly subjects. Am J Epidemiol. 1993;138:56–64.CrossRefPubMed
34.
35.
Aydinoğlu NZ, Krishna A. Imagining thin: why vanity sizing works. J Consum Psychol. 2012;22:565–72.CrossRef
36.
Howard SJ, Davies SC. Chief medical officer urges action to tackle overweight and obesity. BMJ. 2014;348:g2375.CrossRefPubMed
37.
Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17:510–9.CrossRefPubMed
38.
Xu C, Yu C, Ma H, Xu L, Miao M, Li Y. Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai study. Am J Gastroenterol. 2013;108:1299–304.CrossRefPubMed
39.
Loomis AK, Kabadi S, Preiss D, Hyde C, Bonato V, St Louis M, et al. Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies. J Clin Endocrinol Metab. 2016;101:945–52.CrossRefPubMed
40.
Hughes LA, Schouten LJ, Goldbohm RA, van den Brandt PA, Weijenberg MP. Self-reported clothing size as a proxy measure for body size. Epidemiology. 2009;20:673–6.CrossRefPubMed
41.
Battram DS, Beynon C, He M. The reliability and validity of using clothing size as a proxy for waist circumference measurement in adults. Appl Physiol Nutr Metab. 2011;36:183–90.CrossRefPubMed
Metadata
Title
Association between skirt size and chronic liver disease in post-menopausal women: a prospective cohort study within the United Kingdom Trial of Ovarian Cancer Screening (UKCTOCS)
Authors
P. M. Trembling
S. Apostolidou
A. Gentry-Maharaj
J. Parkes
A. Ryan
S. Tanwar
M. Burnell
U. Menon
W. M. Rosenberg
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-018-5308-x

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue

Research article

Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy

Research article

“We find what we look for, and we look for what we know”: factors interacting with a mental health training program to influence its expected outcomes in Tunisia

Research article

Cluster randomised trial of a school-community child health promotion and obesity prevention intervention: findings from the evaluation of fun ‘n healthy in Moreland!

Research article

Understanding how outcomes are measured in workplace physical activity interventions: a scoping review

Research article

Pain and self-rated health among middle-aged and older Canadians: an analysis of the Canadian community health survey―healthy aging

Research article

Adherence to the Qatar dietary guidelines: a cross-sectional study of the gaps, determinants and association with cardiometabolic risk amongst adults